您的位置: 首页 > 农业专利 > 详情页

: Preparation and Use of Human CD124 and CD116 Positive Tumor Cell Lines for Preparation of Allogeneic or Semi-Allogeneic
专利权人:
Glycotope GmbH
发明人:
SCHEPER, Rik, J.,MASTERSON, Alan,PINEDO, Herbert, M.,GOLETZ, Steffen
申请号:
DK02758474
公开号:
DK1419240T4
申请日:
2002.08.19
申请国别(地区):
DK
年份:
2018
代理人:
摘要:
Preparing effective dendritic cells or cell lines (A) comprising treating cells (B) of CD124- and CD116-positive lines with at least one stimulatory molecule (I), applied at the same time or sequentially, is new. Independent claims are also included for the following: (1) preparing a pharmaceutical composition by producing (A) by the new method then formulating with carrier and optionally an adjuvant; (2) kit or test system containing (A); and (3) test system comprising (i) CD124- and CD116-positive or (ii) MUTZ-3 cells. ACTIVITY : Cytostatic; Antirheumatic; Immunosuppressive; Immunostimulatory; Antibacterial; Virucide; Antiparasitic; Fungicide; Dermatological; Antiinflammatory; Antianemic; Nephrotropic; Thyrotropic; Antidiabetic; Anthelmintic; Protozoacide. No biological data given. MECHANISM OF ACTION : Vaccine; Immunotherapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充